| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.3M | -16.5% |
| Cost of Revenue | $51.7M | +152.0% |
| Gross Profit | -$45.4M | -250.1% |
| R&D Expense | $11.8M | -72.4% |
| SG&A Expense | $23.5M | +4.1% |
| Operating Income | -$89.8M | -4.5% |
| Net Income | -$86.2M | -11.1% |
| EPS (Basic) | -$7.32 | -1425.0% |
| EPS (Diluted) | -$7.32 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.3M | -33.8% |
| Accounts Receivable | $215K | -89.2% |
| Inventory | $5.6M | +67.6% |
| Current Assets | $43.4M | -63.3% |
| Total Assets | $71.8M | -49.9% |
| Current Liabilities | $27.6M | +39.6% |
| Total Liabilities | $42.9M | +7.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$72.2M | -31.6% |
| Capital Expenditures | $7.3M | +26.0% |
| Investing Cash Flow | $64.8M | +329.7% |
| Financing Cash Flow | $174K | -99.3% |
| Free Cash Flow | -$79.5M | -31.0% |
| -1425.0% |
| Stockholders' Equity |
| $28.9M |
| -72.1% |